Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2015)

Summary

Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2015) is a study catalogued by cBioPortal DataHub under the cancer-type code bll. EvidenceHelix groups it with blood, lymph and bone marrow studies.

Study description

Comprehensive profiling of infant MLL-rearranged acute lymphoblastic leukemia (MLL-R ALL)

Text as published in the source's study metadata.

Citation & PubMed

Andersson et al. Nat Genet 2015

Linked PubMed records: PMID 25730765

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

all_stjude_2015

Short name

ALL (St. Jude 2015)

Source cancer-type code

bll

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Andersson et al. Nat Genet 2015

• PubMed record 25730765 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2016)

  Whole-genome and/or whole-exome sequencing of ERG-altered B-ALL tumor/normal pairs.

  Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1

• Pediatric Acute Lymphoid Leukemia - Phase II (TARGET, 2018)

  Whole genome or whole exome sequencing on 298 Pediatric Acute Lymphoid Leukemia - Phase II samples. Comprehensive profiling of ALL Phase 2 samples. TARGET data is intended exclusively for biomedical research using ped…

  Blood, lymph and bone marrowNCI TARGETSource code bll

• Acute Myeloid Leukemia (OHSU, Cancer Cell 2022)

  Whole-exome and transcriptomic sequencing of 942 acute myeloid leukemia samples (with 500 matched normals) from the Beat AML program.

  Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1

• Acute Myeloid Leukemia (OHSU, Nature 2018)

  Whole-exome sequencing of 672 acute myeloid leukemia samples (with 454 matched normals) from the Beat AML program.

  Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1

• Acute myeloid leukemia or myelodysplastic syndromes (WashU, 2016)

  Enhanced exome or targeted sequencing of 116 acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) patients' tumor/normal pairs .

  Blood, lymph and bone marrowOther published and consortium studiesSource code mnmPubMed 1

• Chronic Lymphocytic Leukemia (Broad, Cell 2013)

  Whole-exome sequencing of 160 CLL tumor/normal pairs.

  Blood, lymph and bone marrowOther published and consortium studiesSource code cllsllPubMed 1

• Chronic Lymphocytic Leukemia (Broad, Nature 2015)

  Whole exome sequencing of 537 chronic lymphocytic leukemia tumor/normal pairs.

  Blood, lymph and bone marrowOther published and consortium studiesSource code cllsllPubMed 1

• Chronic Lymphocytic Leukemia (Broad, Nature Genetics 2022)

  Whole genome and whole exome sequencing of 1,154 samples from 1,148 patients with Chronic Lymphocytic Leukemia and monoclonal B cell lymphocytosis and their matched normals.

  Blood, lymph and bone marrowOther published and consortium studiesSource code cllsllPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.